Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parallax Behavioral Health was a behavioral health and digital health subsidiary of Parallax Health Sciences focused on software-enabled behavioral care, remote patient monitoring, and outcomes optimization. The company commercialized intellectual property acquired from ProEventa and built around its R.E.B.O.O.T. platform, described as Reliable Evidence Based Outcomes Optimization Technologies, along with a mobile application called MyPath. Its offerings were aimed at improving treatment outcomes and operational performance in behavioral health settings rather than developing traditional drug therapeutics. Public disclosures indicate the business operated as a wholly owned subsidiary within Parallax Health Sciences and later sold certain intellectual property in 2022.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parallax Behavioral Health.